Skip to main content
    P

    Precigen Inc (PGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.30
    -0.24 (-5.29%)

    Market Cap: $1.63B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Precigen Inc (PGEN) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Precigen (PGEN) to earn $0.25 per share in the fiscal year ending Dec 31, 2026, on revenue of $241.76M. Of 4 analysts, 3 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.

    RatingAnalystsShare
    Strong Buy125.0%
    Buy250.0%
    Hold125.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 148.0% and revenue estimates rise 84.7%.

    Fiscal year ending Dec 31, 2026
    $0.25
    EPS consensus, revenue $241.76M
    Fiscal year ending Dec 31, 2027
    $0.62
    EPS consensus, revenue $446.43M
    Next report
    Mar 23, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.25$0.23 to $0.273$241.76M$241.05M to $242.82M3
    Dec 31, 2027$0.62$0.43 to $0.954$446.43M$385.20M to $523.34M4

    Quarterly Estimates

    The EPS consensus rises from $0.12 for the quarter ending Dec 31, 2026 to $0.15 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.12$0.11 to $0.146$89.64M$81.44M to $94.97M6
    Mar 31, 2027$0.15$0.13 to $0.172$97.70M$97.70M to $97.70M1

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202620
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 13.6% from $0.22.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.25$0.22$0.22$0.22$0.22+11.8%
    Fiscal year ending Dec 31, 2027$0.62$0.62$0.63$0.68$0.68-9.5%
    Quarter ending Mar 31, 2027$0.15$0.17$0.17$0.17$0.17-11.8%

    Frequently Asked Questions About PGEN

    What is the PGEN stock forecast?

    Consensus analyst estimates put Precigen's EPS at $0.25 for the fiscal year ending Dec 31, 2026, on revenue of $241.76M. The consensus rating from 4 analysts is Buy.

    How do analysts rate PGEN stock?

    Of 4 analysts covering Precigen, 1 rates it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from PGEN next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.25, with estimates from $0.23 to $0.27 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.62, with estimates from $0.43 to $0.95 from 4 analysts.

    What revenue do analysts expect from Precigen next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $241.76M, with estimates from $241.05M to $242.82M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $446.43M, with estimates from $385.20M to $523.34M.

    How many analysts cover PGEN?

    4 analysts rate Precigen stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.